Details for New Drug Application (NDA): 201961
✉ Email this page to a colleague
The generic ingredient in PHENTERMINE HYDROCHLORIDE is phentermine hydrochloride. There are seventeen drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the phentermine hydrochloride profile page.
Summary for 201961
Tradename: | PHENTERMINE HYDROCHLORIDE |
Applicant: | Lannett Co Inc |
Ingredient: | phentermine hydrochloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 201961
Physiological Effect | Appetite Suppression Increased Sympathetic Activity |
Suppliers and Packaging for NDA: 201961
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PHENTERMINE HYDROCHLORIDE | phentermine hydrochloride | CAPSULE;ORAL | 201961 | ANDA | Lannett Company, Inc. | 0527-1743 | 0527-1743-01 | 100 CAPSULE in 1 BOTTLE (0527-1743-01) |
PHENTERMINE HYDROCHLORIDE | phentermine hydrochloride | CAPSULE;ORAL | 201961 | ANDA | Lannett Company, Inc. | 0527-1743 | 0527-1743-10 | 1000 CAPSULE in 1 BOTTLE (0527-1743-10) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 37.5MG | ||||
Approval Date: | Jul 20, 2011 | TE: | RLD: | No |
Complete Access Available with Subscription